Published in Z Gastroenterol on October 01, 2006
How to treat esophageal perforations when determinants and predictors of mortality are considered. World J Surg (2009) 0.90
Implantation of a colorectal stent as a therapeutic approach in the treatment of esophageal leakage. BMC Gastroenterol (2007) 0.75
Proteinase K from Tritirachium album Limber. Eur J Biochem (1974) 3.41
Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet (1992) 3.33
Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet (1993) 3.20
Local control of the immune response in the liver. Immunol Rev (2000) 3.01
Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology (2007) 2.99
Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med (1990) 2.36
HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology (1991) 2.24
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet (1994) 2.14
Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib. Ann Oncol (2010) 2.11
Small solid renal masses: characterization by diffusion-weighted MRI at 3 T. Clin Radiol (2013) 2.08
Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology (1998) 1.98
HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol (1997) 1.97
Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. Hepatology (1999) 1.79
Detection of RET proto-oncogene codon 634 mutations using mass spectrometry. J Mol Med (Berl) (1997) 1.77
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut (2000) 1.70
Serological pattern "anti-HBc alone": report on a workshop. J Med Virol (2000) 1.65
Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol (1995) 1.59
Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG). Genitourin Med (1996) 1.58
A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol (1998) 1.56
Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology (1999) 1.54
Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum Mol Genet (1994) 1.51
Helicobacter sp. strain Mainz isolated from an AIDS patient with septic arthritis: case report and nonradioactive analysis of 16S rRNA sequence. J Clin Microbiol (1994) 1.45
Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet (1987) 1.43
[The role of diffusion 3-Tesla MRI in detecting prostate cancer before needle biopsy: multiparametric study of 111 patients]. J Radiol (2010) 1.43
Epithelial cell-derived components induce transforming growth factor-alpha mRNA expression and epithelial cell proliferation in vitro. Eur J Gastroenterol Hepatol (2001) 1.39
Leber's hereditary optic neuroretinopathy, a mitochondrial disease? Lancet (1984) 1.34
IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin Exp Immunol (1998) 1.32
Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants. Hepatology (1995) 1.32
Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology (1996) 1.32
Ouabain application to the round window of the gerbil cochlea: a model of auditory neuropathy and apoptosis. J Assoc Res Otolaryngol (2001) 1.31
Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab (1997) 1.31
Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin. Diabetes Obes Metab (2005) 1.30
Gene deletions in X-linked muscular dystrophy. Am J Hum Genet (1989) 1.29
Characterization of a G protein-coupled receptor for nicotinic acid. Mol Pharmacol (2001) 1.28
The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response. J Hepatol (1999) 1.27
[A glucose dehydrogenase for the determination of glucose concentrations in body fluids (author's transl)]. Z Klin Chem Klin Biochem (1975) 1.26
X-linked myopathy with excessive autophagy: a new hereditary muscle disease. Ann Neurol (1988) 1.26
Autoimmune hepatitis following hepatitis A virus infection. J Hepatol (1995) 1.26
Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology (1999) 1.25
Inhibition of IKs in guinea pig cardiac myocytes and guinea pig IsK channels by the chromanol 293B. Pflugers Arch (1996) 1.24
In vitro secretion of anti-GOR protein and anti-hepatitis C virus antibodies in patients with chronic hepatitis C. Gastroenterology (1994) 1.24
Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta. J Viral Hepat (2001) 1.23
Liver resection of colorectal metastases in elderly patients. Br J Surg (2010) 1.21
Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology (1999) 1.21
Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity. Gut (2005) 1.20
Acute management of refractory variceal bleeding in liver cirrhosis by self-expanding metal stents. Digestion (2012) 1.19
Management of concomitant hepatic artery injury in patients with iatrogenic major bile duct injury after laparoscopic cholecystectomy. Br J Surg (2008) 1.18
Coping, distress, and survival among patients with lung cancer. Arch Gen Psychiatry (1999) 1.17
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat (2006) 1.17
Analytical performance characteristics and clinical utility of a novel assay for total hepatitis C virus core antigen quantification. J Clin Microbiol (2010) 1.16
Dark lumen magnetic resonance colonography: comparison with conventional colonoscopy for the detection of colorectal pathology. Gut (2003) 1.16
Long-term experience after ex situ liver surgery. Surgery (2000) 1.16
Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol (1996) 1.16
Prokinetics in patients with gastroparesis: a systematic analysis. Digestion (1999) 1.16
Growth regulation of normal thyroids and thyroid tumors in man. Recent Results Cancer Res (1990) 1.16
Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells. J Immunol (1999) 1.13
Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology (1995) 1.13
Meta-analysis of tumor recurrence after liver transplantation for hepatocellular carcinoma based on 1,198 cases. Eur J Med Res (2007) 1.13
Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice. Hepatology (1996) 1.12
Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. Z Gastroenterol (2001) 1.12
Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma. Genes Chromosomes Cancer (1995) 1.10
AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma. World J Gastroenterol (2007) 1.10
Ultraviolet-light-induced conformational changes in DNA. Photochem Photobiol (1973) 1.10
Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver (1994) 1.10
The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers. J Gen Virol (1994) 1.09
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study). Ann Oncol (2014) 1.07
"PMN-elastase assay": enzyme immunoassay for human polymorphonuclear elastase complexed with alpha 1-proteinase inhibitor. J Clin Chem Clin Biochem (1984) 1.07
Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg (2000) 1.06
Monoclonal antibodies against inhibin represent key markers of adult granulosa cell tumors of the ovary even in their metastases. A report of three cases with late metastasis, being previously misinterpreted as hemangiopericytoma. Am J Surg Pathol (1995) 1.06
Creatine kinase, an enzyme of many forms. Clin Chem (1982) 1.06
MHC class II genes influence the susceptibility to chronic active hepatitis C. J Hepatol (1997) 1.05
Proximal versus distal gastric carcinoma--what are the differences? Ann Surg Oncol (2000) 1.05
Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med (1995) 1.05
Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients: part I. Differences due to the acquisition of HIV-infection. Eur J Med Res (2003) 1.04
Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. J Hepatol (1999) 1.04
Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis. Hepatology (1996) 1.04
Pre-attentive detection of vowel contrasts utilizes both phonetic and auditory memory representations. Brain Res Cogn Brain Res (1999) 1.03
Adeno-associated virus-mediated gene delivery into the scala media of the normal and deafened adult mouse ear. Gene Ther (2011) 1.03
Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection. J Med Virol (1998) 1.02
Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B. Liver (1998) 1.02
Natural history of residual renal stone fragments after ESWL. Eur Urol (2000) 1.02
Hepatic expression patterns of the large and middle hepatitis B virus surface proteins in viremic and nonviremic chronic hepatitis B. Gastroenterology (1990) 1.01
Prevalence of unexplained upper abdominal symptoms in patients with migraine. Cephalalgia (2006) 1.01
[Determination of creatine kinase-MB in serum using inhibiting antibodies (author's transl)]. Klin Wochenschr (1976) 1.00
Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation. J Hepatol (2000) 1.00
Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years. Surgery (2001) 1.00
HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines. Clin Exp Immunol (1999) 1.00
Lipid metabolism in the liver. Z Gastroenterol (2007) 1.00
Duration of immunosuppressive therapy in autoimmune hepatitis. J Hepatol (2001) 0.99
Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. J Hepatol (1998) 0.99
The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation. Aliment Pharmacol Ther (2005) 0.99
[Diagnosis and treatment of colorectal liver metastases - workflow]. Zentralbl Chir (2008) 0.98
Receptor-mediated entry of hepatitis B virus particles into liver cells. Arch Virol (1997) 0.98
Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohistochemical characterization, and relation to markers of autoimmunity. Hepatology (1995) 0.98